Epizyme

$9.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-0.72%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Epizyme and other stocks, options, and ETFs commission-free!

About EPZM

Epizyme, Inc. Common Stock, also called Epizyme, is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. The listed name for EPZM is Epizyme, Inc. Common Stock.

CEO
Robert B. Bazemore
Employees
304
Headquarters
Cambridge, Massachusetts
Founded
2007
Market Cap
1.05B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
956.20K
High Today
$9.86
Low Today
$9.42
Open Price
$9.72
Volume
1.16M
52 Week High
$23.61
52 Week Low
$9.42

EPZM News

BenzingaFeb 23

Return On Capital Employed Overview: Epizyme

In Q4, Epizyme (NASDAQ:EPZM) posted sales of $8.38 million. Earnings were up 14.23%, but Epizyme still reported an overall loss of $62.14 million. Epizyme colle
BenzingaFeb 23

Epizyme: Q4 Earnings Insights

Shares of Epizyme (NASDAQ:EPZM) rose 3.4% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 10.17% o

EPZM Earnings

-$0.74
-$0.49
-$0.25
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.58 per share
Actual
-$0.65 per share
Replay Earnings Call

You May Also Like

AHH-A
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure